CN107518414A - A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof - Google Patents
A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof Download PDFInfo
- Publication number
- CN107518414A CN107518414A CN201710695222.3A CN201710695222A CN107518414A CN 107518414 A CN107518414 A CN 107518414A CN 201710695222 A CN201710695222 A CN 201710695222A CN 107518414 A CN107518414 A CN 107518414A
- Authority
- CN
- China
- Prior art keywords
- albumen
- antifatigue
- trace element
- vitamin
- peptide combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 51
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000011573 trace mineral Substances 0.000 claims abstract description 67
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 67
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 44
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 44
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 42
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 229960003080 taurine Drugs 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 20
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 19
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011777 magnesium Substances 0.000 claims abstract description 19
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 19
- 239000011701 zinc Substances 0.000 claims abstract description 19
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000011575 calcium Substances 0.000 claims abstract description 18
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 18
- 239000011734 sodium Substances 0.000 claims abstract description 18
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 17
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 13
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 13
- 239000011720 vitamin B Substances 0.000 claims abstract description 13
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 12
- 239000002131 composite material Substances 0.000 claims abstract description 12
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 12
- 239000011710 vitamin D Substances 0.000 claims abstract description 12
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 12
- 229940046008 vitamin d Drugs 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 11
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 11
- 239000011719 vitamin A Substances 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- 229940045997 vitamin a Drugs 0.000 claims abstract description 11
- 235000013361 beverage Nutrition 0.000 claims description 26
- 239000007787 solid Substances 0.000 claims description 26
- 229940091250 magnesium supplement Drugs 0.000 claims description 18
- 229960005069 calcium Drugs 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 108010073771 Soybean Proteins Proteins 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- 229940001941 soy protein Drugs 0.000 claims description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 4
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 4
- 239000001354 calcium citrate Substances 0.000 claims description 4
- 239000001508 potassium citrate Substances 0.000 claims description 4
- 229960002635 potassium citrate Drugs 0.000 claims description 4
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 4
- 235000011082 potassium citrates Nutrition 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 4
- 239000011670 zinc gluconate Substances 0.000 claims description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims description 4
- 229960000306 zinc gluconate Drugs 0.000 claims description 4
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- 239000001755 magnesium gluconate Substances 0.000 claims description 3
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 3
- 229960003035 magnesium gluconate Drugs 0.000 claims description 3
- 239000000395 magnesium oxide Substances 0.000 claims description 3
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000019710 soybean protein Nutrition 0.000 claims description 3
- 239000011576 zinc lactate Substances 0.000 claims description 3
- 235000000193 zinc lactate Nutrition 0.000 claims description 3
- 229940050168 zinc lactate Drugs 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000004384 Neotame Substances 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 2
- 235000019412 neotame Nutrition 0.000 claims description 2
- 108010070257 neotame Proteins 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- 244000228451 Stevia rebaudiana Species 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical group O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 8
- 229930003231 vitamin Natural products 0.000 abstract description 8
- 235000013343 vitamin Nutrition 0.000 abstract description 8
- 239000011782 vitamin Substances 0.000 abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 8
- 239000013589 supplement Substances 0.000 abstract description 6
- 230000019522 cellular metabolic process Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 3
- 239000002207 metabolite Substances 0.000 abstract description 3
- 239000002250 absorbent Substances 0.000 abstract description 2
- 230000002745 absorbent Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 24
- 206010016256 fatigue Diseases 0.000 description 23
- 235000018102 proteins Nutrition 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 239000000047 product Substances 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical group [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to technical field of health care food, and in particular to a kind of antifatigue oligomeric peptide combinations of albumen and preparation method thereof.Said composition is made up of following raw material：Albumen oligopeptide 70~75%, taurine 1~2%, B B-complex 0.2~0.5%, composite trace element 0.2~0.5%；Wherein B B-complex by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio composition；Composite trace element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：1：1：2：1 mass ratio composition.The quick absorbent properties of albumen oligopeptide promote body to absorb taurine, vitamin and trace element; nutriment needed for the vitamin and trace element supplement cell metabolism of compounding; discharge unnecessary metabolite; promote body to absorb the nutritional ingredients such as albumen oligopeptide, taurine, lift antifatigue health-care effect.
Description
Technical field
The present invention relates to technical field of health care food, and in particular to a kind of oligomeric peptide combinations of antifatigue albumen and its preparation
Method.
Background technology
Fatigue has turned into a very universal problem of today's society, investigates and shows according to WHO, the whole world has at more than 35% people
In fatigue state, and middle-aged male accounting is 60%.During manual labor, if metabolite can not be stopped by appropriate
Breath or other modes are removed, and body tiredness will be produced in vivo to a certain extent by assembling, and mental activity is easily given
It is artificial into high-strung state, if can not be eased in time will produce psychological fatigue.
The continuous development of fatigue level of human body, lie dormant huge threat to health, and the confirmed fatigue of long term accumulation is often
The immune organ and tissues such as the thymus gland adrenaline of body can be caused to occur to sexually revise and atrophy and deterioration occur, caused
Immune function of human body reduces, and various psychosomatics connect bell and arrived, i.e. people's usually said " falling sick from overwork ".
Sleep is a kind of mode of most direct dispelling fatigue.The mesh of dispelling fatigue can also be reached by dietetic regulation
's.In motion process, the synthesis of protein is suppressed body, while skeletal muscle protein is degraded, amino-acid oxidase and Portugal
Grape gluconeogenesis strengthens, and cause vivo protein utilizes increase, causes skeletal muscle to produce damage, and energetic supersession material subtracts
It is few, so as to influence the performance of locomitivity, therefore make up disappearing for vivo protein in time from external supplement protein after exercise
Consumption, is the simple effective method of quick dispelling fatigue in order to avoid causing the negative balance of skeletal muscle protein.
But the product that current supplement is protein-based, such as albumen powder, the protein included when interior absorption of human body utilizes,
Generally require first to become amino acid in vivo, then synthesis polypeptide, then by intestinal absorption, the slow-footed shortcoming of absorption be present,
Human body needs the energy for consuming itself to go to absorb protein, causes current albumen powder product to be unsuitable for digestive system and does not send out
It is bred as ripe infant, digestive system starts the elderly of degeneration and is badly in need of nitrogen source because of overexercise and can not increase intestines
The sportsman and physical labourer of stomach function burden.
Albumen oligopeptide is that a kind of molecular weight is small, and the mixture of the small-molecular peptides containing several amino acids composition can be fast
Speed is absorbed by the body, and human body, which is not required to digest, directly absorbs supplement body nitrogen source, can provide energy rapidly, have and accelerate muscle tired
Labor recovers function.Therefore, the defects of overcoming traditional protein powder to be not easy to be digested absorption, people start to use albumen oligopeptide conduct
Anti-fatigue health-product containing is made in raw material, but wants fatigue-relieving, recovers body activities ability, it is necessary to improves and adjusts cell generation
Thank, in addition to requiring supplementation with protein, it is also desirable to the synergy of necessary vitamin and electrolyte etc., but current egg
White oligomeric peptide product adds the vitamin used, electrolyte etc. due to selection and aids in the formula of active ingredient and proportioning improper,
Antifatigue improvement still can not meet consumer demand.
The content of the invention
The defects of in order to overcome prior art, it is an object of the invention to provide a kind of antifatigue oligomeric peptide combinations of albumen,
Formula is reasonable, various ingredients synergy, anti-fatigue health-caring significant effect.
Meanwhile the present invention is also providing a kind of preparation method of the antifatigue oligomeric peptide combinations of albumen.
In order to realize the above object the technical solution adopted in the present invention is：
A kind of oligomeric peptide combinations of antifatigue albumen, are mainly prepared by the raw material of following weight percent dosage：Albumen
Oligopeptide 70~75%, taurine 1~2%, B B-complex 0.2~0.5%, composite trace element 0.2~0.5%；Wherein
B B-complex is by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio composition；It is compound micro
Element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：1：1：2：1 matter
Amount is than composition.
Preferably, the above-mentioned oligomeric peptide combinations of antifatigue albumen, mainly by following weight percent dosage raw material prepare and
Into：Albumen oligopeptide 75%, taurine 1.5%, B B-complex 0.3%, composite trace element 0.2%.
Optionally, the oligomeric peptide combinations of the albumen are solid beverage；The raw material also includes sweetener 3~8%, auxiliary material
15~25%.Wherein auxiliary material is the carbohydrate for having abundant product special flavour, extending the shelf life commonly used in solid beverage
Material, such as glucose, citric acid, preservative etc..
Preferably, above-mentioned antifatigue albumen oligopeptide solid beverage, is prepared by the raw material of following weight percent dosage：
Albumen oligopeptide 75%, taurine 1.5%, B B-complex 0.3%, composite trace element 0.2%, auxiliary material 18%, sweetener
5%.
Optionally, the sweetener is one kind or any combination in stevioside, neotame and Sucralose.
Optionally, the albumen oligopeptide is soy protein oligopeptide, soy protein oligopeptide mean molecule quantity is 600~
800Da, prepared by soybean protein by enzymolysis or acid-hydrolyzed mode.
Optionally, the source of the microelements of calcium is calcium citrate, calcium gluconate, one kind in calcium lactate or any
Combination；The source of trace element magnesium is magnesium sulfate, magnesia, one kind or any combination in magnesium gluconate；Trace element zinc
Source for zinc gluconate, zinc citrate, one kind or any combination in zinc lactate；The source of trace elements K is glucose
Sour potassium and/or potassium citrate；The source of micro- sodium is sodium chloride and/or sodium citrate.
The above-mentioned oligomeric peptide combinations of antifatigue albumen, including each raw material of form of powdery particles is taken, it is well mixed, that is, completes.
Small molecular protein peptide is because its molecular weight is small, mean molecule quantity 600-800Da, and amino acid composition is complete, by 2-10
Individual amino acids formed straight chain oligopeptides or small-molecular peptides.Small molecular protein peptide can not only provide the energy thing of physical activity needs
Matter, enhancing antioxidant ability of organism, homoiostasis and enzymatic activity are maintained, also there is the function such as prevent neurotransmitter unbalance,
This is the advantages of other antifatigue factors is incomparable.
Albumen oligopeptide, molecular weight is small, and amino acid composition is complete, is a kind of based on the small of 2~10 amino acid chains
The mixture of molecular peptide, can have the characteristics of infiltration rate is fast, and absorption efficiency is good, energy as the energy source of tired body
The enough fatigue for effectively alleviating body.Excessive motion can cause largely to consume albumen with pressure, cause sense of fatigue to increase, and at this moment should
The raw material for synthesizing new albumen can be provided by supplementing high-quality albumen in time.Small molecular protein peptide has the score more runs smaller than protein
Son amount, it is easier to be absorbed by organisms utilization, the nitrogen source needed for rapid recharge body.Zoopery shows, small molecular protein peptide energy
The content of hepatic glycogen and muscle glycogen during increase mouse movement.
Taurine is a kind of nonprotein amino acid needed by human, is nutriment main in mammal body, often
For medicine, food additives as biochemical reagents and the intermediate of other organic syntheses.Supplemented with exogenous taurine can phase
The biosynthesis of internal taurine should be reduced, makes the color beautiful protein synthesis of more sulfur-containing amino acid, accordingly improves protein
Quality, make it easier to be absorbed and used, improve the utilization rate of protein, and locomitivity to body and antifatigue have
Certain effect.Experiment shows that taurine can improve or stablize the BCAA concentration in body, is played at antifatigue aspect important
Effect.
Vitamin B is to alleviate pressure, the natural antidote of trophic nerve, helps the metabolite accumulated in human body to use up
Dispose soon, promote body to absorb protein-based nutrient, be the essential nutrient of dispelling fatigue.
Increase VC can promote the release in the horizontal oxygen of tissue during motion, contribute to body body to absorb more iron.Meanwhile
VC reproducibilities are very strong, participate in creatine and protein metabolism, VC is to improving endurance, dispelling fatigue and promoting wound healing helpful.
The antifatigue oligomeric peptide combinations of albumen of the present invention, given birth to albumen oligopeptide, taurine, vitamin B, vitamin C, dimension
Plain A, vitamin D, microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium, which compound to be used as, to be had
Composition is imitated, the quick absorbent properties collaboration of albumen oligopeptide promotes body to absorb taurine, vitamin and trace element, more
The vitamin and trace element of kind compounding supplement the nutriment needed for cell metabolism comprehensively, discharge unnecessary cell metabolism production
Thing, lifting and the eubolism for recovering cell, promote body to absorb the nutritional ingredients such as albumen oligopeptide, taurine, lifted
The antifatigue health-care effect of product.
The preparation method of the antifatigue oligomeric peptide combinations of albumen of the present invention, using it is simple it is dry-mixed by the way of be prepared into solid
Beverage, it is easy to operate, it is easily controllable, suitable for industrial application.
Embodiment
Technical scheme is described in detail below by specific embodiment.
For the albumen oligopeptide used in following embodiments for soy protein oligopeptide, mean molecule quantity is 600~800Da,
Prepared by soybean protein by enzymolysis or acid-hydrolyzed mode；
Auxiliary material is the carbohydrate material for having abundant product special flavour, extending the shelf life commonly used in solid beverage,
Such as glucose, citric acid, preservative etc., the health-care efficacy antifatigue to product do not have an impact effect；
The oligomeric peptide combinations of antifatigue albumen in following embodiments are solid beverage, are used only for the technology to the present invention
Scheme is done for example, product type has no effect on the antifatigue health-care efficacy of product of the present invention, for example can also be liquid drink
Material etc..
Embodiment 1
A kind of antifatigue albumen oligopeptide solid beverage, is prepared by the raw material of following weight percent dosage：Albumen is low
Poly- peptide 75%, taurine 1.5%, B B-complex 0.3%, composite trace element 0.2%, auxiliary material 18%, stevioside 5%；Its
Middle B B-complex is by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio composition；It is compound micro-
Secondary element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：1：1：2：1 amount
Than composition.
The source of the microelements of calcium is calcium citrate；The source of trace element magnesium is magnesium sulfate；Trace element zinc
Source is zinc gluconate；The source of trace elements K is K-IAO；The source of secondary element sodium is sodium chloride.
The preparation method of above-mentioned antifatigue albumen oligopeptide solid beverage, including each raw material of form of powdery particles is taken, mix
Uniformly, that is, complete.
Embodiment 2
A kind of antifatigue albumen oligopeptide solid beverage, is prepared by the raw material of following weight percent dosage：Albumen is low
Poly- peptide 70%, taurine 1%, B B-complex 0.5%, composite trace element 0.5%, auxiliary material 25%, knob sugar 3%；It is wherein multiple
Vitamin is closed by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio composition；Compound micro member
Element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：1：1：2：1 quality
Than composition.
The source of the microelements of calcium is calcium citrate and calcium gluconate；The source of trace element magnesium be magnesium sulfate and
Magnesia；The source of trace element zinc is zinc gluconate and zinc citrate；The source of trace elements K is potassium citrate；It is micro
The source of elements of Na is sodium citrate.
The preparation method of above-mentioned antifatigue albumen oligopeptide solid beverage, including each raw material of form of powdery particles is taken, mix
Uniformly, that is, complete.
Embodiment 3
A kind of antifatigue albumen oligopeptide solid beverage, is prepared by the raw material of following weight percent dosage：Albumen is low
Poly- peptide 74.5%, taurine 2%, B B-complex 0.2%, composite trace element 0.3%, auxiliary material 15%, stevioside 8%；Its
Middle B B-complex is by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio composition；It is compound micro-
Secondary element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：1：1：2：1
Mass ratio forms.
The source of the microelements of calcium is calcium lactate；The source of trace element magnesium is magnesium gluconate；Trace element zinc
Source be zinc lactate；The source of trace elements K is potassium citrate；The source of micro- sodium is sodium citrate.
The preparation method of above-mentioned antifatigue albumen oligopeptide solid beverage, including each raw material of form of powdery particles is taken, mix
Uniformly, that is, complete.
Comparative example 1
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, deproteinized oligopeptide is saved, is added
Legumin 75% is increased, other are the same as embodiment 1.
Comparative example 2
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, saves vitamin C, vitamin
A and vitamin D, the dosage for adjusting vitamin B is 0.3%, and other are the same as embodiment 1.
Comparative example 3
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, saves vitamin B, vitamin
A and vitamin D, it is 0.3% to adjust ascorbic dosage, and other are the same as embodiment 1.
Comparative example 4
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, saves vitamin B, vitamin
C and vitamin D, the dosage for adjusting vitamin A is 0.3%, and other are the same as embodiment 1.
Comparative example 5
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, saves vitamin C, vitamin
A and vitamin B, the dosage for adjusting vitamin D is 0.3%, and other are the same as embodiment 1.
Comparative example 6
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, save trace element magnesium, micro-
Secondary element zinc, trace elements K, micro- sodium, the dosage for adjusting microelements of calcium is 0.2%, and other are the same as embodiment 1.
Comparative example 7
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, save microelements of calcium, micro-
Secondary element zinc, trace elements K, micro- sodium, the dosage for adjusting trace element magnesium is 0.2%, and other are the same as embodiment 1.
Comparative example 8
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, save trace element magnesium, micro-
Secondary element calcium, trace elements K, micro- sodium, the dosage for adjusting trace element zinc is 0.2%, and other are the same as embodiment 1.
Comparative example 9
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, save trace element magnesium, micro-
Secondary element zinc, microelements of calcium, micro- sodium, the dosage for adjusting trace elements K is 0.2%, and other are the same as embodiment 1.
Comparative example 10
The antifatigue albumen oligopeptide solid beverage of this comparative example, as different from Example 1, save trace element magnesium, micro-
Secondary element zinc, microelements of calcium, trace elements K, the dosage for adjusting micro- sodium is 0.2%, and other are the same as embodiment 1.
Comparative example 11
The antifatigue albumen oligopeptide solid beverage of this comparative example, is prepared by the raw material of following parts by weight：Soybean is low
Poly- 12.5 parts of peptide, 12.5 parts of animal oligopeptides, 4 parts of VBT, 1.5 parts of taurine, 0.5 part of electrolyte, 1 part of sweetener, auxiliary material 68
Part.
Test method
1st, general information：Randomly select 25~40 years old sports fatigue, manual labor fatigue, mental labour fatigue, immunity
The volunteer 480 of low fatigue, is randomly divided into 12 groups, every group of 40 volunteers；
2nd, diagnostic criteria：Sense of fatigue is mitigated, and the state of mind be improved significantly be designated as effectively；Can not be obvious
Feel that sense of fatigue is mitigated, the state of mind it is bad be designated as it is invalid；
3rd, treatment method：
12 groups of volunteers after fatigue is felt, every group of one-to-one corresponding respectively with warm water take after mixing it with water embodiment 1, comparative example 1~
10 15~the 20g of solid beverage prepared, after 30 minutes, the effective percentage mitigated after taking to sense of fatigue is counted, as a result such as table 1 below institute
Show：
Table 1
From the result shown in above-mentioned table 1, the anti-fatigue health-caring effect of solid beverage prepared by the embodiment of the present invention 1 is bright
It is aobvious be better than comparative example 1~10, it can be seen that, it is of the invention by by vitamin B, vitamin C, vitamin D, vitamin A, micro member
Plain calcium, trace element magnesium, trace element zinc, micro- sodium, trace elements K are used in combination, after comprehensive supplement organism fatigue
Trace element and vitamin needed for metabolism, body can be promoted to absorb albumen oligopeptide and taurine, lifting and recovery
Organism metabolism, body is set effectively to produce energy, dispelling fatigue.Synergistic function, lifting production are played between each raw material
The antifatigue health-care effect of product.
The technical concepts and features of certain the various embodiments described above and test example only to illustrate the invention, it is ripe its object is to allow
Present disclosure can be understood and implement according to this by knowing the people of technique, and it is not intended to limit the scope of the present invention.
The modification that all Spirit Essences according to main technical schemes of the present invention are done, should all cover within protection scope of the present invention.
Claims (9)
1. a kind of oligomeric peptide combinations of antifatigue albumen, it is characterised in that mainly prepared by the raw material of following weight percent dosage
Form：Albumen oligopeptide 70~75%, taurine 1~2%, B B-complex 0.2~0.5%, composite trace element 0.2~
0.5%；Wherein B B-complex by vitamin B, vitamin C, vitamin A and vitamin D according to 4：4：1：1 mass ratio group
Into；Composite trace element is by microelements of calcium, trace element magnesium, trace element zinc, trace elements K, micro- sodium according to 2：
1：1：2：1 mass ratio composition.
2. the antifatigue oligomeric peptide combinations of albumen as claimed in claim 1, it is characterised in that mainly used by following weight percent
The raw material of amount is prepared：Albumen oligopeptide 75%, taurine 1.5%, B B-complex 0.3%, composite trace element
0.2%.
3. the antifatigue oligomeric peptide combinations of albumen as claimed in claim 1, it is characterised in that the oligomeric peptide combinations of albumen
For solid beverage；The raw material also includes sweetener 3~8%, auxiliary material 15~25%.
4. the antifatigue oligomeric peptide combinations of albumen as claimed in claim 3, it is characterised in that by following weight percent dosage
Raw material is prepared：It is albumen oligopeptide 75%, taurine 1.5%, B B-complex 0.3%, composite trace element 0.2%, auxiliary
Material 18%, sweetener 5%.
5. the oligomeric peptide combinations of antifatigue albumen as described in claim 3 or 4, it is characterised in that the sweetener is stevia rebaudianum
Sugar, neotame and one kind or any combination in Sucralose.
6. the oligomeric peptide combinations of antifatigue albumen as described in any one of Claims 1 to 4, it is characterised in that the albumen is low
Poly- peptide is soy protein oligopeptide.
7. the antifatigue oligomeric peptide combinations of albumen as claimed in claim 6, it is characterised in that the soy protein oligopeptide is put down
Average molecular weight is 600~800Da, is prepared by soybean protein by enzymolysis or acid-hydrolyzed mode.
8. the oligomeric peptide combinations of antifatigue albumen as described in any one of Claims 1 to 4, it is characterised in that the micro member
The source of plain calcium is calcium citrate, calcium gluconate, one kind or any combination in calcium lactate；The source of trace element magnesium is sulphur
One kind or any combination in sour magnesium, magnesia, magnesium gluconate；The source of trace element zinc is zinc gluconate, citric acid
One kind or any combination in zinc, zinc lactate；The source of trace elements K is K-IAO and/or potassium citrate；Micro member
The source of plain sodium is sodium chloride and/or sodium citrate.
9. a kind of oligomeric peptide combinations of antifatigue albumen as described in any one of Claims 1 to 4, it is characterised in that including taking
Each raw material of form of powdery particles, it is well mixed, that is, completes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710695222.3A CN107518414A (en) | 2017-08-15 | 2017-08-15 | A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710695222.3A CN107518414A (en) | 2017-08-15 | 2017-08-15 | A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107518414A true CN107518414A (en) | 2017-12-29 |
Family
ID=60681101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710695222.3A Pending CN107518414A (en) | 2017-08-15 | 2017-08-15 | A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107518414A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109984245A (en) * | 2019-04-16 | 2019-07-09 | 中国热带农业科学院南亚热带作物研究所 | A kind of Queensland nut protein peptides and its preparation method and application having anti-fatigue effect |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1729875A (en) * | 2005-08-18 | 2006-02-08 | 北京康比特威创体育新技术发展有限公司 | Sports drink |
| CN1792257A (en) * | 2005-12-31 | 2006-06-28 | 北京康比特威创体育新技术发展有限公司 | Protein rod |
| CN105495262A (en) * | 2015-12-17 | 2016-04-20 | 重庆都好生物科技有限公司 | Double-protein-peptide anti-fatigue solid beverage |
| CN106135907A (en) * | 2015-04-11 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to resisting fatigue |
| CN106889619A (en) * | 2017-03-06 | 2017-06-27 | 青岛海大华旗生物科技有限公司 | It is a kind of to promote health food of post-operative recovery and preparation method thereof |
| CN106889412A (en) * | 2017-01-17 | 2017-06-27 | 安徽元麦凡康食品有限公司 | One kind is refreshed oneself anti-fatigue solid beverage |
| CN106912962A (en) * | 2017-03-16 | 2017-07-04 | 海门元生医学科技发展有限公司 | A kind of health food for lifting the Health Status of Elders and preparation method thereof |
-
2017
- 2017-08-15 CN CN201710695222.3A patent/CN107518414A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1729875A (en) * | 2005-08-18 | 2006-02-08 | 北京康比特威创体育新技术发展有限公司 | Sports drink |
| CN1792257A (en) * | 2005-12-31 | 2006-06-28 | 北京康比特威创体育新技术发展有限公司 | Protein rod |
| CN106135907A (en) * | 2015-04-11 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | A kind of alimentation composition contributing to resisting fatigue |
| CN105495262A (en) * | 2015-12-17 | 2016-04-20 | 重庆都好生物科技有限公司 | Double-protein-peptide anti-fatigue solid beverage |
| CN106889412A (en) * | 2017-01-17 | 2017-06-27 | 安徽元麦凡康食品有限公司 | One kind is refreshed oneself anti-fatigue solid beverage |
| CN106889619A (en) * | 2017-03-06 | 2017-06-27 | 青岛海大华旗生物科技有限公司 | It is a kind of to promote health food of post-operative recovery and preparation method thereof |
| CN106912962A (en) * | 2017-03-16 | 2017-07-04 | 海门元生医学科技发展有限公司 | A kind of health food for lifting the Health Status of Elders and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109984245A (en) * | 2019-04-16 | 2019-07-09 | 中国热带农业科学院南亚热带作物研究所 | A kind of Queensland nut protein peptides and its preparation method and application having anti-fatigue effect |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jäger et al. | International society of sports nutrition position stand: protein and exercise | |
| CN106721843B (en) | Double-bacterial protein solid beverage | |
| CN104256595B (en) | A kind of many polymerizers of whole protein type enteral nutrition | |
| CN105145846A (en) | Nutritional bag for increasing bone density and improving osteoporosis | |
| CN108651998A (en) | It is a kind of have relieve fatigue PURE WHEY of function and preparation method thereof | |
| CN101036519A (en) | Nutritive powder and its making process | |
| KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
| CN103783532A (en) | Compound protein powder for resisting age-related sarcopenia, and preparation methods thereof | |
| CN106343580A (en) | Novel high-calcium nutrient protein powder and preparation method thereof | |
| CN105495262A (en) | Double-protein-peptide anti-fatigue solid beverage | |
| WO2006062273A1 (en) | Branched-amino acid supplement food | |
| GB2268871A (en) | Composition for use as a food or food supplement | |
| WO1994001006A2 (en) | Composition for use as a food or food supplement | |
| CN105614228A (en) | Chenopodium quinoa willd multi-vitamin nutrition powder processing method | |
| CN107232471A (en) | A kind of nutrient solid beverage | |
| CN103622121B (en) | A kind of solid beverage containing glutamine dipeptide | |
| CN110584101A (en) | Pont bird's nest, preparation method and beverage | |
| CN106912962A (en) | A kind of health food for lifting the Health Status of Elders and preparation method thereof | |
| RU2609813C1 (en) | Functional food product "amino jam" | |
| CN111513224A (en) | Solid beverage suitable for endurance exercise | |
| CN1127070A (en) | Healthful nutrition milk powder and production method | |
| CN110959796A (en) | Solid drink of sport and body-building mate and preparation method thereof | |
| CN113875792A (en) | Meal replacement compressed biscuit beneficial to maintaining health of skin mucosa and preparation method thereof | |
| CN107518414A (en) | A kind of oligomeric peptide combinations of antifatigue albumen and preparation method thereof | |
| CN101642155A (en) | Antioxidant and body-building beauty healthcare biscuit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171229 |
|
| RJ01 | Rejection of invention patent application after publication |